- Home
- FTLF vs ACTU Comparison
FTLF vs ACTU Comparison
Compare FTLF & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTLF
- ACTU
- Stock Information
- Founded
- FTLF 2005
- ACTU 2015
- Country
- FTLF United States
- ACTU United States
- Employees
- FTLF N/A
- ACTU N/A
- Industry
- FTLF Medicinal Chemicals and Botanical Products
- ACTU
- Sector
- FTLF Health Care
- ACTU
- Exchange
- FTLF Nasdaq
- ACTU NYSE
- Market Cap
- FTLF 145.8M
- ACTU 162.1M
- IPO Year
- FTLF N/A
- ACTU 2024
- Fundamental
- Price
- FTLF $15.44
- ACTU $7.69
- Analyst Decision
- FTLF Strong Buy
- ACTU
- Analyst Count
- FTLF 1
- ACTU 0
- Target Price
- FTLF $20.00
- ACTU N/A
- AVG Volume (30 Days)
- FTLF 15.2K
- ACTU 20.8K
- Earning Date
- FTLF 03-04-2025
- ACTU 03-04-2025
- Dividend Yield
- FTLF N/A
- ACTU N/A
- EPS Growth
- FTLF 93.67
- ACTU N/A
- EPS
- FTLF 0.85
- ACTU N/A
- Revenue
- FTLF $62,755,000.00
- ACTU N/A
- Revenue This Year
- FTLF $25.54
- ACTU N/A
- Revenue Next Year
- FTLF $7.30
- ACTU N/A
- P/E Ratio
- FTLF $18.16
- ACTU N/A
- Revenue Growth
- FTLF 40.17
- ACTU N/A
- 52 Week Low
- FTLF $10.51
- ACTU $5.51
- 52 Week High
- FTLF $17.75
- ACTU $11.73
- Technical
- Relative Strength Index (RSI)
- FTLF 49.41
- ACTU N/A
- Support Level
- FTLF $14.75
- ACTU N/A
- Resistance Level
- FTLF $15.49
- ACTU N/A
- Average True Range (ATR)
- FTLF 0.63
- ACTU 0.00
- MACD
- FTLF 0.00
- ACTU 0.00
- Stochastic Oscillator
- FTLF 35.29
- ACTU 0.00
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, and sports drink products, meal replacement products and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products and Supplements.
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.